4o09: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
'''Unreleased structure'''
{{STRUCTURE_4o09|  PDB=4o09  |  SCENE=  }}
===Identification of novel HSP90 / isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington s disease===
{{ABSTRACT_PUBMED_24673104}}


The entry 4o09 is ON HOLD until Paper Publication
==Function==
[[http://www.uniprot.org/uniprot/HS90A_HUMAN HS90A_HUMAN]] Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Undergoes a functional cycle that is linked to its ATPase activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognition, ATPase cycle and chaperone function.<ref>PMID:15937123</ref> <ref>PMID:11274138</ref>  


Authors: Zuccola, H.J., Ernst, J.T.
==About this Structure==
[[4o09]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4O09 OCA].  


Description: Identification of novel HSP90 / isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington s disease
==Reference==
<ref group="xtra">PMID:024673104</ref><references group="xtra"/><references/>
[[Category: Ernst, J T.]]
[[Category: Zuccola, H J.]]
[[Category: Chaperone]]
[[Category: Chaperone-chaperone inhibitor complex]]

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA